• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Monday 11/19/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Chill Gummy

  • PotNetwork Holdings
    11:46 AM

    Jun 27, 2017, POTN OTC Disclosure & News Service – PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that the Company’s subsidiary, Diamond CBD, has entirely sold out of its increasingly popular proprietary Chill Gummy line. The past six months of trade show, expo, and convention attendance have demonstrated Management’s determined commitment to achieve strong results, yielding in product demand requiring significant expansion of its manufacturing operations. The Company’s Chill Gummy inventory is slated to be restocked within approximately two weeks.

    Read more
  • PotNetwork Holdings
    7:28 AM

    Results Continue to Exceed Expectations as Diamond CBD’s Premium Product Line is Showcased at the World’s Largest and Most Trusted Counter-Culture Trade Show FT LAUDERDALE, Fla.– POTN, (BUSINESS WIRE)– PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce today that its wholly owned subsidiary, Diamond CBD, after achieving a record breaking first quarter revenues, has achieved sales results in excess of $235,000 for the Company’s premium Cannabidiol (CBD) hemp oil and other products that it featured at the CHAMPS

    Read more
  • 1:46 PM

    Clinical Advisory Board Chairman Dr. Joseph Jurcic Presents Data From Ongoing Actimab-A Phase I/II Clinical Trial NEW YORK, NY–(Marketwired – May 29, 2015) -Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced its poster and abstract at ASCO 2015, the 51st Annual Meeting of American Society of Clinical Oncology, held in Chicago on May 29 – June 2. Data will be presented from the Company’s ongoing multi-center

    Read more
  • 1:02 PM

      MONTREAL, QC, Apr 29, 2014 (Marketwired via COMTEX) — Sunshine Biopharma, Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer today announced that it has entered into an Investment Agreement with Dutchess Opportunity Fund, II, LP (“Dutchess”). Dutchess has agreed to purchase up to $2.5 million of shares of Sunshine’s Common Stock over a three-year commitment period. Under the terms of the Investment Agreement Sunshine

    Read more
Public Wire Banner